	US 12,102,707 B2
	Skin care composition
Tomohiro Hakozaki, Cincinnati, OH (US); Bin Fang Deyer, Loveland, OH (US); and Leo Timothy Laughlin, II, Mason, OH (US)
Assigned to The Procter & Gamble Company, Cincinnati, OH (US)
Filed by The Procter & Gamble Company, Cincinnati, OH (US)
Filed on Aug. 28, 2023, as Appl. No. 18/456,625.
Application 18/456,625 is a continuation of application No. 16/455,988, filed on Jun. 28, 2019, granted, now 11,786,451.
Prior Publication US 2023/0404892 A1, Dec. 21, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 8/67 (2006.01); A61K 8/04 (2006.01); A61K 8/29 (2006.01); A61K 8/34 (2006.01); A61K 8/368 (2006.01); A61K 8/86 (2006.01); A61K 8/891 (2006.01); A61K 8/9783 (2017.01); A61Q 19/02 (2006.01)

CPC A61K 8/675 (2013.01) [A61K 8/04 (2013.01); A61K 8/29 (2013.01); A61K 8/342 (2013.01); A61K 8/347 (2013.01); A61K 8/368 (2013.01); A61K 8/86 (2013.01); A61K 8/891 (2013.01); A61K 8/9783 (2017.08); A61Q 19/02 (2013.01)]

13 Claims

1. A topical skin care composition, comprising:

a. a hydrolysate comprising an aqueous extract of Nymphaea alba flowers and thermally inactivated enzymes; wherein the hydrolysate comprises from about 20% to about 70% carbohydrate, by weight of the dry matter of the hydrolysate;

b. a vitamin B₃compound; and

c. a dermatologically acceptable carrier.